1. Market Research
  2. > Biotechnology Market Trends
  3. > Accident & Emergency Partnering 2010-2015

Accident & Emergency Partnering 2010-2015

  • May 2015
  • -
  • Currentpartnering
  • -
  • 100 pages

Summary
Accident & Emergency Partnering 2010-2015 report provides understanding and access to the accident & emergency partnering deals and agreements entered into by the worlds leading healthcare companies

Description

Accident & Emergency Partnering 2009-2014 report provides understanding and access to the accident & emergency partnering deals and agreements entered into by the worlds leading healthcare companies.

•Trends in accident & emergency partnering deals
•Top accident & emergency deals by value
•Deals listed by company A-Z, industry sector, stage of development, technology type
Accident & Emergency Partnering 2009-2014 provides understanding and access to the accident & emergency partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of accident & emergency partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors accident & emergency technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 120 links to online copies of actual accident & emergency deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of accident & emergency partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in accident & emergency partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading accident & emergency deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive directory of accident & emergency partnering deals signed and announced since 2009. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of accident & emergency technologies and products.

Report scope

Accident & Emergency Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to accident & emergency trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

•Trends in accident & emergency dealmaking in the biopharma industry since 2009
•Access to summary headline, upfront, milestone and royalty data
•The leading accident & emergency deals by value since 2009

In Accident & Emergency Partnering 2009-2014, the available deals are listed by:

•Headline value
•Upfront payment value
•Royalty rate value
•Company A-Z
•Industry sector
•Stage of development at signing
•Deal component type
•Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


Benefits

Accident & Emergency Partnering 2009-2014 provides the reader with the following key benefits:


•In-depth understanding of accident & emergency deal trends since 2009
•Access to summary headline, upfront, milestone and royalty data
•Comprehensive access to over 120 actual accident & emergency deals entered into by the world’s biopharma companies since 2009
•Insight into key deal terms included in contracts, where disclosed
•Understand the key deal terms companies have agreed in deals
•Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Keywords

accident, emergency, hospital care, partnering, licensing, deals, alliances, merger and acquisition, M&A, big pharma

Table Of Contents

Accident and Emergency Partnering 2010-2015
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Accident and Emergency partnering

2.1. Introduction
2.2. Accident and Emergency partnering over the years
2.3. Big pharma Accident and Emergency dealmaking activity
2.4. Big biotech Accident and Emergency dealmaking activity
2.5. Most active Accident and Emergency dealmakers
2.6. Accident and Emergency partnering by deal type
2.7. Accident and Emergency partnering industry sector
2.8. Accident and Emergency partnering by stage of development
2.9. Accident and Emergency partnering by technology type
2.10. Disclosed financial deal terms for Accident and Emergency
2.10.1 Accident and Emergency headline values
2.10.2 Accident and Emergency upfront payments
2.10.3 Accident and Emergency milestone payments
2.10.4 Accident and Emergency royalty rates

Chapter 3 - Leading Accident and Emergency deals

3.1. Introduction
3.2. Top Accident and Emergency deals by value

Chapter 4 - Dealmaking directory

4.1. Introduction
4.2. Company A-Z
4.3. By deal type
4.4. By industry sector
4.5. By stage of development
4.6. By technology type

Chapter 5 - Partnering resource center

5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking

Appendices

Appendix 1 - Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form - Reports
Order Form - Subscription Access Products

Table of figures

Figure 1: Accident and Emergency partnering since 2009
Figure 2: Big pharma - top 50 - Accident and Emergency deals 2009 to 2014
Figure 3: Big pharma Accident and Emergency deal frequency - 2009 to 2014
Figure 4: Big biotech - top 50 - Accident and Emergency deals 2009 to 2014
Figure 5: Big biotech Accident and Emergency deal frequency - 2009 to 2014
Figure 6: Accident and Emergency dealmaking activity- 2009 to 2014
Figure 7: Accident and Emergency partnering by deal type since 2009
Figure 8: Accident and Emergency partnering by industry sector since 2009
Figure 9: Accident and Emergency partnering by stage of development since 2009
Figure 10: Accident and Emergency partnering by technology type since 2009
Figure 11: Accident and Emergency deals with a headline value
Figure 12: Accident and Emergency deals with upfront payment values
Figure 13: Accident and Emergency deals with milestone payments
Figure 14: Accident and Emergency deals with royalty rates, %
Figure 15: Top Accident and Emergency deals by value since 2009
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

  • $ 18000
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global bioreactors market is expected to reach to USD 1,417 million by 2021 from USD 955 million in 2015, at a CAGR of 6.8% between 2015 and 2021.The increase in adoption of single-use technologies, ...

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.